Wash. Admin. Code § 388-60B-0410

Current through Register Vol. 24-23, December 1, 2024
Section 388-60B-0410 - Placement criteria-How must a program determine a participant's level of treatment?
(1) For level one treatment the program must ensure:
(a) A program must place participants in level one treatment if the program has documented through the assessment, collateral contacts, the participant's legal history and the "risks, needs and responsivity" form all of the following:
(i) The participant has no previous domestic violence charges regardless of an arrest or legal outcomes;
(ii) The participant is at an overall low risk for lethality or recidivism; and
(iii) The participant has engaged in abusive and controlling behavior with an intimate partner;
(b) If the program cannot obtain information from all of the sources in this section then the program must document their reasonable efforts to obtain the information and must place the participant in level two, three, or four treatment; and
(c) A participant who has already been placed in a higher level of treatment must not be transferred to level one treatment at any time.
(2) For level two treatment the program must ensure:
(a) A program must place participants in level two treatment if the program has determined through the assessment, collateral contacts, the participant's legal history, the assessment process and the "risks, needs and responsivity" form the following:
(i) The participant is at an overall medium risk for lethality or recidivism;
(ii) The participant has an established pattern of abuse and control; and
(iii) The participant has little or no criminogenic needs; and
(b) If the program cannot obtain information from any of the sources in this section, then the program must document their reasonable efforts to obtain the information.
(3) For level three treatment, the program must ensure the program places participants in level three treatment if the program has documented through the assessment, collateral contacts, the participant's legal history and the 'risks, needs and responsivity' form the following:
(a) The participant is at an overall high risk for lethality or recidivism;
(b) The participant has indicated an acute or critical assessment factor as specified in WAC 388-60A-0400(15) and 388-60A-0400(16); or
(c) The participant has identified antisocial traits; and
(d) The participant has criminogenic needs which can be addressed in group or through ancillary individual sessions, depending on their unique risks and needs as identified in the participant's assessment and outlined in their treatment plan.
(4) For level four treatment, the program must ensure:
(a) The participant's risks and needs indicate a medium or high level of psychopathy as identified through a combination of information from:
(i) The assessment;
(ii) Collateral sources;
(iii) The participant's legal history; and
(iv) A relevant assessment tool which may include but is not limited to:
(A) The Self-Report Psychopathy Scale (SRP4);
(B) The PCL-SV or PCL-R which may include the IM-P;
(C) The Hare P-scan; or
(D) Other evidence-based measures of psychopathy; and
(b) Level four treatment may be facilitated through group or individual sessions or a combination of group and individual sessions in order to meet the participant's unique treatment needs as outlined in their treatment plan.
(5) Levels one and two treatment may be combined in the same group.
(6) Level three treatment participants may be combined with levels one and two or in a separate group, depending on the individual treatment needs and goals of each participant.
(7) Participants in level four treatment must be in a separate group from all other participants in lower levels of treatment and must not be combined with any other groups at any time.

Wash. Admin. Code § 388-60B-0410

WSR 19-15-044, recodified as § 388-60B-0410, filed 7/11/19, effective 7/28/19. WSR 18-14-078, recodified as § 110-60A-0410, filed 6/29/18, effective 7/1/18

Statutory Authority: RCW 26.50.150. WSR 18-12-034, § 388-60A-0410, filed 5/29/18, effective 6/29/18.